Hepatic, Metabolic and Toxic Effects of Ethanol: 1991 Update

Alcoholism: Clinical and Experimental Research

Volumn 15, Issue 4, 1991, Pages 573-592

  Lieber, Charles S ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Acetaldehyde; Ethanol Metabolism; Hepatotoxicity; Microsomes

Indexed keywords

ACETALDEHYDE; CYTOCHROME P450; GLUTATHIONE; RETINOL;

ALCOHOLISM; HUMAN; LIVER DISEASE; MALNUTRITION; METABOLISM; PRIORITY JOURNAL; REVIEW;

ACETALDEHYDE; ANIMAL; ETHANOL; HUMAN; LIVER; MICROSOMES, LIVER; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026042412     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1991.tb00563.x     Document Type: Review

References (234)

1. Fatty liver, hyperlipemia and hyperuricemia produced by prolonged alcohol consumption, despite adequate dietary intake
2. Liquid diet technique of ethanol administration: 1989 update
3. The feeding of ethanol in liquid diets: 1986 update
4. Biological effects of chronic ethanol consumption: A reappraisal of the Lieber‐DeCarli liquid‐diet model with reference to skeletal muscle
5. Quantitative relationship between the amount of dietary fat and the severity of the alcoholic fatty liver
6. Protein deficiency alters rat pancreatic lipid composition
7. The combined effects of protein deficiency and chronic ethanol administration on rat ethanol metabolism
8. The combined effects of protein deficiency and chronic ethanol consumption on the rat pancreas
9. Nutrition in Pancreatic and Liver Disorders
10. Alcohol and the digestive tract
11. Effects of prolonged ethanol intake: Production of fatty liver despite adequate diets
12. Alcoholic fatty liver in man on a high protein and low fat diet
13. An experimental model of alcohol feeding and liver injury in the baboon
14. Alcohol and dietary factors in cirrhosis. An epidemiological study of 304 alcoholic patients
15. Effect of riboflavine deficiency on bone marrow function and protein metabolism in baboons
16. Sequential production of fatty liver, hepatitis and cirrhosis in sub‐human primates fed ethanol with adequate diets
17. Choline fails to prevent liver fibrosis in ethanol‐fed baboons but causes toxicity
18. Polyunsaturated lecithin (PUL) protects against alcoholic cirrhosis in the baboon
19. Histogenesis of alcohol fibrosis and cirrhosis in the baboon
20. Morphometry of terminal hepatic veins. 1. Comparative study in man and baboon
21. Morphometry of terminal hepatic veins. 2. Follow up in chronically alcohol‐fed baboons
22. Is ethanol per se hepatotoxic
23. Is alcohol hepatotoxic in the baboon
24. Mechanism for selective perivenular hepatotoxicity of ethanol
25. Alcoholic hepatotoxicity
26. Genetic polymorphism and susceptibility to alcoholic liver disease
27. 2‐receptor antagonists, and its effect on the bioavailability of ethanol
28. First pass metabolism of ethanol a gastrointestinal barrier against the systemic toxicity of ethanol
29. First pass metabolism of ethanol: An important determinant of blood levels after alcohol consumption
30. Effects of cimetidine on gastric alcohol dehydrogenase activity and blood ethanol levels
31. Effects of fasting and chronic alcohol consumption on the first pass metabolism of ethanol
32. Aspirin increases blood alcohol concentrations in human after ingestion of ethanol
33. Effects of omeprazole, cimetidine and ranitidine on blood ethanol concentrations
34. High blood alcohol levels in women: Role of decreased gastric alcohol dehydrogenase activity and first pass metabolism
35. A public health approach for the control of the disease of alcoholism
36. Evidence for increased urate production by acitvation of adenine nucleotide turnover
37. Role of xanthine oxidase in ethanol‐induced lipid peroxidation in rats
38. Ethanol and lipids
39. Role of dietary, adipose and endogenously synthesized fatty acids in the pathogenesis of the alcoholic fatty liver
40. Effects of prolonged ethanol intake in man: Role of dietary, adipose, and endogenously synthesized fatty acids in the pathogenesis of the alcoholic fatty liver
41. To drink (moderately) or not to drink
42. Relationship of alcoholic hypertriglyceridemia to stage of liver disease and dietary lipid
43. Effect of ethanol on ketone metabolism
44. Optical measurement of the catalase‐hydrogen peroxide intermediate (compound I) in the liver of anaesthetized rats and its implication to hydrogen peroxide production in situ
45. Fatty acid‐dependent ethanol metabolism
46. Role of peroxisomal fatty acid beta‐oxidation in ethanol metabolism
47. Discussion in microsomes and drug oxidation
48. Ultrastructural alterations in human hepatocytes following ingestion of ethanol with adequate diets
49. Ethanol oxidation by hepatic microsomes: adaptive increase after ethanol feeding
50. Hepatic microsomal ethanol‐oxidizing system: In vitro characteristics and adaptive properties in vivo
51. Microsomal ethanol‐oxidizing system (MEOS): Purification and properties of a rat liver system free of catalase and alcohol dehydrogenase
52. Ethanol oxidation by a component of liver microsomes rich in cytochrome P‐450
53. Reconstitution of the microsomal ethanol‐oxidizing system: Qualitative and quantitative changes of cytochrome P‐450 after chronic ethanol consumption
54. The direct oxidation of ethanol by catalase‐ and alcohol dehydrogenase‐free reconstituted system containing cytochrome P‐450
55. Purification and characterization of a unique isozyme of cytochrome P‐450 from liver microsomes of ethanol‐treated rabbits
56. Mechanisms of hydroxyl radical formation and ethanol oxidation by ethanol‐inducible and other forms of rabbit liver microsomal cytochromes P‐450
57. Catalytic activity of cytochrome P‐450 isozyme 3a isolated from liver microsomes of ethanol‐treated rabbits
58. Comparison of six rabbit liver cytochrome P‐450 isozymes in formation of a reactive metabolite of acetaminophen
59. Carbon tetrachloride‐induced lipid peroxidation dependent on an ethanol‐inducible form of, rabbit liver microsomal cytochrome P‐450
60. Metabolism of nitrosamines by purified rabbit liver cytochrome P‐450 isozymes
61. Benzene metabolism by ethanol‐, acetone‐, and benzene‐inducible cytochrome P‐450 (IIE1) in rat and rabbit liver microsomes
62. Characterization of a major form of rat hepatic microsomal cytochrome P‐450 induced by isoniazid
63. Evidence that isoniazid and ethanol induced the same microsomal cytochrome P‐450 in rat liver, and isozyme homologous to rabbit liver cytochrome P‐450 isozymes 3a
64. Purification and characterization of ethanol‐inducible human hepatic cytochrome P‐450H1j
65. Complementary DNA and protein sequences of ethanol‐inducible rat and human cytochrome P‐450s
66. Purification and characterization of human liver cytochrome P‐450‐ALC
67. The P‐450 gene superfamily: Recommended nomenclature
68. Characterization of a benzoflavone (BQ‐inducible hamster liver cytochrome P‐450 isozyme catalytically similar to cytochrome P‐450‐ALC
69. Role of acetone, dietary fat, and total energy intake in the induction of the hepatic microsomal ethanol oxidizing system
70. Molecular regulation of ethanol inducible cytochrome P450IIE1 in hamsters
71. The rat P450IIEl gene: Complete intron and exon sequence, chromosome mapping, and correlation of development expression with specific 5′ cytosine demethylation
72. Human ethanol‐inducible P450IIE1: Complete gene sequence, promoter characterization chromosome mapping, and cDNA‐directed expression
73. Ethanol metabolism in peromyscus genetically deficient in alcohol dehydrogenase
74. Ethanol metabolizing pathways in deermice: Estimation of flux calculated from isotope effects
75. Biochemical and molecular basis for alcohol‐induced injury to liver and other tissues
76. Increased rate of clearance of drugs from the circulation of alcoholics
77. Increase of ethanol meprobamate and pentobarbital metabolism after chronic ethanol administration in man and in rats
78. Increased rate of tolbutamide metabolism in alcoholic patients
79. Differences in the duration of the enhancement of liver mixed‐function oxidase activities in ethanol‐fed rats after withdrawal
80. Effect of ethanol on benzodiazepine disposition in dogs
81. Short‐term ethanol administration impairs the elimination of chlordiazepoxide (Librium) in man
82. Effect of short‐term ethanol administration on lorazepam clearance
83. Intravenous diazepam and oral ethanol interaction
84. Amitriptyline and ethanol: pharmacokinetic and pharmacodynamic interaction
85. Inhibition of drug metabolism by acute ethanol intoxication. An hepatic micr, somal mechanism
86. Mechanism of the effect of acute ethanol on hexobarbital metabolism
87. Ethanol inhibition of codeine and morphine metabolism in isolated rat hepatocytes
88. Interaction of methadone and ethanol metabolism
89. Effects of acute alcohol administration on propranolol absorption
90. Metabolic interaction between n‐xylene and ethanol
91. Increased carbon tetrachloride hepatotoxicity, and its mechanism, after chronic ethanol consumption
92. The intralobular distribution of ethanol‐inducible P450IIE1 in rat and human liver
93. Effects of ethanol and phenobarbital administration on the metabolism and toxicity of benzene
94. Kinetic studies on benzene metabolism in rat liver‐Possible presence of three forms of benzene metabolizing enzymes in the liver
95. Identification and induction of cytochromes P450, P450IIE1 and P450IA1 in rabbit bone marrow
96. Effect of chronic ethanol administration on bromobenzene liver toxicity in the rat
97. Influence of alcohol, dithiocard and (+)‐catechin on the hepatotoxicity and metabolism of vinylidene chloride in rats
98. Inhibition and stimulation of enflurane metabolism in the rat following a single dose or chronic administration of ethanol
99. Interaction of ethanol with enflurane metabolism and toxicity: Role of P450IIEl
100. Potentiation of halo‐thane hepatotoxicity by chronic ethanol administration in rat: An animal model of halothane hepatitis
101. Characterization of halothane oxidation by hepatic microsomes and purified cytochrome P‐450 using a gas chromatographic mass spectrometric assay
102. Effect of combined phenylbutazone and ethanol administration on rat liver
103. Acetaminophen hepatotoxicity
104. Acetaminophen hepatotoxicity in alcoholics (Clinical review)
105. Increased hepatotoxicity of acetaminophen after chronic ethanol consumption in the rat
106. Mechanism of preventative effect on acetaminophen‐induced hepatotoxicity
107. Interaction of acute ethanol administration with acetaminophen metabolism and toxicity in rats fed alcohol chronically
108. Interaction of ethanol with acetaminophen metabolism in the baboon
109. Ethanol potentiation of liver injury
110. Cocaine‐induced liver cell injury: Comparison of morphological features in man and in experimental models
111. Potentiation of the hepatotoxicity of N‐nitrosodimethylamine by fasting, diabetes, acetone and isopropanol
112. Alcohol and cancer
113. Enhancement of dimethylnitrosamine metabolism and activation to a mutagen following chronic ethanol consumption
114. Effect of chronic ethanol consumption on activation of nitrosopymolidine to a mutagen by rat upper alimentary tract, lung and hepatic tissue
115. Enhanced pulmonary and intestinal activation of procarcinogens and mutagens after chronic ethanol consumption in the rat
116. Ethanol and intestinal carcinogenesis in the rat
117. Immunohistochemical localization of ethanol‐inducible P450IIE1 in the rat alimentary tract
118. Alcohol and cancer
119. Hepatic vitamin A depletion in alcoholic liver injury
120. Hepatic vitamin A depletion after chronic ethanol consumption in baboons and rats
121. New pathway for retinol metabolism in liver microsomes
122. +‐dependent retinol dehydrogenase in liver microsomes
123. Retinoic acid metabolism by a system reconstituted with cytochrome P‐450
124. Metabolism of retinol and retinoic acid by human liver cytochrome P4501IC8
125. Potentiation of ethanol‐induced hepatic vitamin A depletion by phenobarbital and butylated hydroxy‐toluene
126. Decreased hepatic vitamin A after drug administration in men and in rats
127. Increased vitamin A in esophagus and other extrahepatic tissues after chronic ethanol consumption in the rat
128. Effect of hepatic vitamin A depletion on the liver in human and rats
129. Interaction of drugs and retinol
130. The Mallory body: structure, composition, and pathogenesis
131. Hypervitaminosis A A liver lover's lament
132. Hepatotoxicity of vitamin A and ethanol in the rat
133. Hepatic fibrosis after long term administration of ethanol and moderate vitamin A supplementation in the rat
134. The effect of alcohol (ethanol) administration on sex hormone metabolism in normal men
135. Interrelationships between vitamin D3 and 25‐hydroxyl‐vitamin D3 during chronic ethanol administration in the rat
136. Role of intestinal bacterial overgrowth on ethanol production and metabolism in rats
137. Metabolic homeostasis of L‐threonine in the normally‐fed rat
138. High levels of acetaldehyde in non‐alcoholic liver injury after threonine or ethanol administration
139. Red blood cells: A new major pathway for acetaldehyde transport from liver to other tissues
140. Comparative subcellular distribution of aldehyde dehydrogenase in rat, mouse and rabbit liver
141. Electrophoretic and biochemical studies of human aldehyde dehydrogenase isozymes in various tissues
142. Molecular abnormality of an inactive aldehyde dehydrogenase variant commonly found in Orientals
143. m, ALDH isozyme and alcoholic liver injury
144. Acetaldehyde oxidation by hepatic mitochondria: Its decrease after chronic ethanol consumption
145. Determinants of plasma free acetaldehyde level during the steady state oxidation of ethanol: Effects of chronic ethanol feeding
146. Impaired oxygen utilization: A new mechanism for the hepatotoxicity of ethanol in subhuman primates
147. Binding of acetaldehyde to rat liver microsomes: Enhancement after chronic alcohol consumption
148. Formation of acetaldehyde adducts with ethanol‐inducible P450IIE1 in vivo
149. Detection of a protein‐acetaldehyde adduct in the liver of rats fed alcohol chronically
150. Acetaldehyde adducts with proteins: binding of a acetaldehyde to serum albumin
151. Acetaldehyde adducts with hemoglobin
152. Monoclonal and polyclonal antibodies against acetaldehyde‐containing epitopes in acetaldehyde‐protein adducts
153. Humoral immune responses to acetaldehyde adducts in alcoholic patients
154. The role of alcoholism and liver disease in the appearance of serum antibodies against acetaldehyde adducts
155. Acetaldehyde binding increases the catabolism of rat serum low‐density lipoproteins
156. Alcoholic hepatomegaly: Accumulation of protein in the liver
157. Effects of ethanol on liver microtubules and Golgi apparatus
158. Comparison between ballooned hepatocytes occurring in human alcoholic and nonalcoholic liver diseases
159. Pathogenesis of alcohol‐induced accumulation of protein in the liver
160. Effects of ethanol on hepatic protein secretion and microtubules. Possible mediation by acetaldehyde
161. Fatty acid‐binding protein: A major contributor to the ethanol‐induced increase in liver cytosolic proteins in rat
162. Hepatic triacylglycerol synthesizing activity during progression of alcoholic liver injury in the baboon
163. Effects of unsaturated acids on membrane structure and enzyme kinetics
164. Fatty acyl‐CoA as an effector molecule in metabolism
165. Gender differences in the response of hepatic non‐esterified fatty acids (NEFA) and fatty acid‐binding protein (GFABP) to alcohol consumption in rats
166. Increased susceptibility of hepatic mitochondria to the toxicity of acetaldehyde after chronic ethanol consumption
167. Membranes and phospholipids of liver mitochondria from chronic alcoholic rats are resistant to membrane disordering by alcohol
168. The effect of chronic ethanol consumption on temperature‐dependent physical properties of liver mitochondrial membranes
169. Lack of correlation between hepatic mitochondrial membrane structure and functions in ethanol‐fed rats
170. Ethanol and membrane lipids
171. Impaired plasma membrane glycoprotein assembly in the liver following acute ethanol administration
172. Chronic ethanol consumption alters rat liver plasma membranes and potentiates release of alkaline phosphatase
173. Effect of chronic ethanol administration on gamma‐glutamyltransferase activities in plasma and in hepatic plasma membranes of male and female rats
174. Effect of chronic alcohol consumption on the activities of liver plasma membrane enzymes: Gamma‐glutamyltransferase, alkaline phosphatase and 5′‐nucleotidase
175. The effects of alcohol and diet on hepatic and serum gamma‐glutamyltranspeptidase activities
176. Drug tolerance in biomembranes: A spin label study of the effect of ethanol
177. Tolerance and cross‐tolerance in chronic alcoholics: Reduced membrane binding of ethanol and other drugs
178. Chronic ethanol ingestion increases calcium uptake and resistance to molecular disordering by ethanol in liver microsomes
179. Decrease in microviscosity and cholesterol content of rat liver plasma membranes after chronic ethanol feeding
180. The fluidity of plasma membranes from ethanol‐treated rat liver
181. Chronic ethanol increases liver plasma membrane fluidity
182. Effects of vitamin A and ethanol on liver plasma membrane fluidity
183. Hepatic lipid peroxidation: Potentiation by chronic alcohol feeding and attenuation by methionine
184. Effects of chronic ethanol feeding on glutathione turnover in the rat
185. Depression of biliary glutathione excretion by chronic ethanol feeding in the rat
186. Increased loss and decreased synthesis of hepatic glutathione after acute ethanol administration
187. Influence of acute ethanol administration on hepatic glutathione peroxidase and glutathione transferase activities in the rat
188. The cooperative antioxidant role of glutathione with a lipid‐soluble and a water‐soluble antioxidant during peroxidation of liposomes initiated in the aqueous phase and in the lipid phase
189. Role of alcohol dehydrogenase activity and of acetaldehyde in ethanol‐induced ethane and pentane production by isolated perfused rat liver
190. Cleavage of folates during ethanol metabolism. Role of acetaldehyde/xanthine oxidase‐generated superoxide
191. The role of aldehyde oxidase in ethanol‐induced hepatic lipid peroxidation in the rat
192. The influence of alcohol on nutritional status
193. S‐adenosyl‐l‐methionine attenuates alcohol‐induced liver injury in the baboon
194. The pathological significance of lipid peroxidation in oxidative cell injury
195. Vitamins and alcoholism
196. Depressed selenium and vitamin E levels in an alcoholic population: Possible relationship to hepatic injury through increased lipid peroxidation
197. Low blood selenium levels in alcoholics with and without advanced liver disease
198. Decreased serum selenium in alcoholics as related to liver structure and function
199. α‐tocopherol level in liver diseases
200. Effect of heavy alcohol consumption on serum concentration of fat soluble vitamins and selenium
201. Interaction with free radicals and ascorbate
202. Interaction of ascorbate and α‐tocopherol
203. Reduced hepatic α‐tocopherol content after long‐term administration of ethanol to rats
204. Some aspects of antioxidant status in blood from alcoholics
205. Lipid peroxidation and antioxidant defense systems in rat liver after chronic ethanol feeding
206. Evidence for the generation of transaminase inhibitor(s) during ethanol metabolism by rat liver homogenates: A potential mechanism for alcohol toxicity
207. 6methylguanine transferase
208. Increased oxygen radical‐dependent inactivation of metabolic enzymes by liver microsomes after chronic ethanol consumption
209. Liver toxicity encountered in the Veterans Administration trial of disulfiram in alcoholics
210. Presence of nonoxidative ethanol metabolism in human organs commonly damaged by ethanol abuse
211. Fatty acid ethyl ester formation during ethanol metabolism in vivo
212. Nonoxidative ethanol metabolism: Formation of fatty acid ethyl esters by cholesterol esterase
213. Nonoxidative ethanol metabolism in rabbit myocardium: Purification to homogeneity of fatty acyl ethyl ester synthase
214. Perivenular fibrosis in alcoholic liver injury: Ultrastructure of histologic progression
215. Perivenular fibrosis as precursor lesion of cirrhosis
216. Clinicopathological study of alcoholic fibrosis
217. The role of fat‐storing cells in Disse space fibrogenesis in alcoholic liver disease
218. Hepatic fibrosis in alcoholics: Morphologic characteristics, clinical diagnosis, and natural course
219. Ultrastructure of initial stages of perivenular fibrosis in alcohol‐fed baboons
220. Alcoholic liver injury in baboons: transformation of lipocytes to transitional cells
221. Lipocytes and transitional cells in alcoholic liver disease: A morphometric study
222. Acetaldehyde selectively stimulates collagen production in cultured rat liver fat‐storing cells but not in hepatocytes
223. Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat‐storing cells through a protein synthesis‐dependent mechanism
224. Increased type I procollagen mRNA levels and in vitro protein synthesis in the baboon model of chronic alcoholic liver disease
225. Hepatic mammalian collagenase: Development of an assay and demonstration of reversal activity after ethanol consumption
226. Effects of ethanol feeding on hepatic collagen synthesis and degradation in rats
227. Mammalian collagenase increases in early alcoholic liver disease and decreases with cirrhosis
228. Attenuation of alcohol‐induced hepatic fibrosis by polyunsaturated lecithin
229. Haplotype analysis of a type I collagen gene and its association with alcoholic cirrhosis in man